RxDoctor Payments Data
★ My doctorsLook up a doctor →

Anette Garces Dominguez

Endocrinology, Diabetes & Metabolism · Houston, TXNPI 1316223241

Payments from drug & device makers

$20,230in general payments, 2019–2025

Across 1,136 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • Lilly USA, LLC$1K
  • Insulet Corporation$1K
  • Medtronic$1K
  • Tandem Diabetes Care, Inc.$1K
  • Amgen$1K
  • plus $11K from 54 others

What the payments were for

  • Speaking & faculty fees$1,1005%
  • Travel & lodging$9485%
  • Food & beverage$18,15690%
  • Education$260%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk208$2,743
Lilly USA, LLC87$1,462
Insulet Corporation133$1,422
Medtronic(2 entities)28$1,402
Tandem Diabetes Care, Inc.14$1,276
Amgen(2 entities)65$1,270
AstraZeneca(2 entities)50$1,270
Boehringer Ingelheim53$1,055
Dexcom, Inc.34$754
Sanofi-aventis U.S. LLC56$678
Amarin Pharma, Inc.28$580
Xeris Pharmaceuticals, Inc.22$407
Corcept Therapeutics18$373
Abbott28$366
Bayer23$349
Valeritas, Inc.17$327
AbbVie19$313
IBSA Pharma Inc.21$310
Intuity Medical Inc34$285
BD15$285
Amneal Pharmaceuticals LLC21$280
Zealand Pharma US, Inc.14$266
Antares Pharma, Inc.16$250
Mannkind Corporation16$246
Esperion Therapeutics, Inc.15$233
Johnson & Johnson6$209
Radius Health, Inc.10$206
Merck16$191
Companion Medical, Inc.8$122
Cequr Corporation2$111
Clarus Therapeutics Inc.4$104
Shire North American Group Inc5$88
Rhythm Pharmaceuticals, Inc.1$75
Eli Lilly Export S.A. Puerto Rico Branch3$73
Vivus LLC4$67
Amryt Pharma Holdings Ltd3$62
Boston Scientific3$54
Currax Pharmaceuticals LLC4$53
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$52
GRT US Holding, Inc.2$48
Ultragenyx Pharmaceutical Inc.2$46
BETA Bionics, Inc.2$44
Novartis2$42
Nevro Corp.2$39
Tolmar, Inc.2$29
Gilead1$25
Ascendis Pharma Endocrinology Inc1$25
Ipsen Biopharmaceuticals, Inc1$23
Shield Therapeutics Inc1$22
Senseonics, Incorporated1$22
Lifescan, Inc.1$22
Averitas Pharma Inc.1$22
Embecta Corp.1$21
Regeneron Healthcare Solutions, Inc.1$21
Bigfoot Biomedical Inc1$18
Halozyme Inc1$17
Kowa Pharmaceuticals America, Inc.1$17
Bayer Puerto Rico Inc.1$16
Acerus Pharmaceuticals Corporation1$15
Recordati_rare_diseases_inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,230 in reported general payments places this provider in the 70th percentile of 658 endocrinology, diabetes & metabolism providers in Texas.

See all endocrinology, diabetes & metabolism providers in Texas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide195$206,899
TrulicityDulaglutide185$188,518
JardianceEmpagliflozin184$124,031
Synjardy XrEmpagliflozin/Metformin Hcl185$119,751
MounjaroTirzepatide82$89,493
FarxigaDapagliflozin Propanediol54$31,693
Trijardy XrEmpaglifloz/Linaglip/Metformin36$26,787
RybelsusSemaglutide24$25,333
Janumet XrSitagliptin Phos/Metformin Hcl36$22,865
SynthroidLevothyroxine Sodium306$18,844
JanuviaSitagliptin Phosphate21$15,793
Xigduo XrDapaglifloz Propaned/Metformin23$14,748
GlyxambiEmpagliflozin/Linagliptin15$11,607
TradjentaLinagliptin19$11,129
LantusInsulin Glargine,hum.Rec.Anlog79$10,204

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy Xr, Trijardy Xr, Glyxambi, Tradjenta$1,055$302,344456 claims
Lilly USA, LLCTrulicity, Mounjaro, Humalog$1,462$282,211298 claims
Novo NordiskOzempic, Rybelsus$2,743$232,233219 claims
MerckJanumet Xr, Januvia, Janumet$191$48,27670 claims
AstraZenecaFarxiga$1,270$31,69354 claims
AbbVieSynthroid$313$18,844306 claims
Sanofi-aventis U.S. LLCLantus$678$10,20479 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$280$43042 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 658 endocrinology, diabetes & metabolism providers in Texas.

Other endocrinology, diabetes & metabolism in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →